Skip to main content

Carcinoma della prostata: pattern RM metabolici e di vascolarizzazione

  • Chapter
Book cover Imaging RM della prostata

Riassunto

Nell’era dell’imaging molecolare ciò che si chiede alla diagnostica per immagini è avere buona accuratezza nella diagnosi precoce di un’alterazione patologica, sia benigna sia, soprattutto, maligna. La criticità di questo aspetto risulta indiscutibile dal punto di vista oncologico e terapeutico, in cui è di primaria importanza superare i limiti dell’evidenza morfologica; in altre parole, la possibilità di identificare un focus patologico prima ancora che sia morfologicamente apprezzabile cambia necessariamente l’outcome del trattamento [1]. È chiaro che i requisiti richiesti esaltano l’aspetto funzionale delle tecniche utilizzate, come per la diffusione, di cui si è trattato nel capitolo 13. Le altre tecniche che sicuramente esaltano l’aspetto funzionale dell’esame di RM sono la spettroscopia a immagini (1H-MRSI) e lo studio dinamico-perfusionale (DCE-MR). Entrambe offrono la visione di due aspetti fondamentali, riguardanti rispettivamente il metabolismo e la vascolarizzazione, che indirizzano indubbiamente verso una più corretta interpretazione diagnostica, quando ancora la lesione si trova in uno stato di pre-evidenza clinico-morfologica. In tale contesto la RM assume significato di completezza e, secondo l’acquisizione anglosassone, diventa un one-stop-shop examination.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Jadvar H (2009) Molecular imaging of prostate cancer: a concise synopsis. Mol Imaging 8(2):56–64

    CAS  PubMed  Google Scholar 

  2. Arora R, Koch MO, Eble JN et al (2004) Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 100:2362–2366

    Article  PubMed  Google Scholar 

  3. Giannoni E, Fiaschi T, Ramponi G, Chiarugi P (2009) Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 28(20):2074–2086

    Article  CAS  PubMed  Google Scholar 

  4. Weidner N (1995) Intratumoral microvascular density as a prognostic factor in cancer. Am J Pathol 147:9–19

    CAS  PubMed  Google Scholar 

  5. Folkman J (1989) What is evidence that tumors are angiogenesis dependent? J Nat Cancer Inst 82:4–6

    Google Scholar 

  6. Foster D, Xu L (2003) Phospholipase D in cell proliferation and cancer. Mol Cancer Res 1(11):789–800

    CAS  PubMed  Google Scholar 

  7. Kim HJ, Lee YH, Kim CK (2007) Biomarkers of muscle and cartilage damage and inflammation during a 200 km run. Eur J Appl Physiol 99(4):443–447

    Article  CAS  PubMed  Google Scholar 

  8. Costello LC, Franklin RB (2002) Testosterone and prolactin regulation of metabolic genes and citrate metabolism of prostate epithelial cells. Horm Metab Res 34(8):417–424

    Article  CAS  PubMed  Google Scholar 

  9. Zakian KL, Shukla-Dave A, Ackerstaff E et al (2008) 1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization. Cancer Biomark 4(4–5): 263–276

    CAS  PubMed  Google Scholar 

  10. Kurhanewicz J, Vigneron DB, Nelson SJ (2000) Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2:166–189

    Article  CAS  PubMed  Google Scholar 

  11. Sciarra A, Salciccia S, Panebianco V (2008) Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging. Eur Urol 54(3):485–488

    Article  PubMed  Google Scholar 

  12. Claus FG, Hricak H, Hattery RR (2004) Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24 Suppl 1:S167–180

    Article  PubMed  Google Scholar 

  13. Zakian KL, Sircar K, Hricak H et al (2005) Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234(3):804–814

    Article  PubMed  Google Scholar 

  14. Prostate cancer detection: magnetic resonance (MR) spectroscopy imaging. Joan C. Villanova, J. Barcelòm Abdominal Imaging (2007) 32:253–261

    Article  Google Scholar 

  15. Fütterer JJ, Heijmink SW, Scheenen TW et al (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241(2):449–458

    Article  PubMed  Google Scholar 

  16. Hricak H, Choyke PL, Eberhardt SC et al (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243:28–53

    Article  PubMed  Google Scholar 

  17. Nakashima J, Tanimoto A, Imai Y et al (2004) Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 64(1):101–105

    Article  PubMed  Google Scholar 

  18. Scheenen TW, Heijmink SW, Roell SA et al (2007) Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology 245: 507–516

    Article  PubMed  Google Scholar 

  19. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867.

    Article  CAS  PubMed  Google Scholar 

  20. Dvorak HF, Nagy JA, Feng D et al (1999) Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237:97–132

    CAS  PubMed  Google Scholar 

  21. Somford DM, Fütterer JJ, Hambrock T, Barentsz JO (2008) Diffusion and perfusion MR imaging of the prostate. Magn Reson Imaging Clin N Am 16(4):685–695

    Article  PubMed  Google Scholar 

  22. Valerio MC, Panebianco V, Sciarra A et al (2009) Classification of prostatic disease by means of multivariate analysis on in vivo proton MRSI and DCE-MRI data. NMR Biomed [Jul 3 Epub ahead of print]

    Google Scholar 

  23. Sandblom G, Ladjevardi S, Garmo H, Varenhorst E (2008) The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostate. Cancer 112(4):813–819

    Article  PubMed  Google Scholar 

  24. Stefanou D, Batistatou A, Kamina S et al (2004) Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo 18(2):155–160

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Italia

About this chapter

Cite this chapter

Panebianco, V., Lisi, D., Bernardo, S. (2010). Carcinoma della prostata: pattern RM metabolici e di vascolarizzazione. In: Passariello, R., Panebianco, V., Di Silverio, F., Sciarra, A. (eds) Imaging RM della prostata. Springer, Milano. https://doi.org/10.1007/978-88-470-1516-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1516-6_14

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1515-9

  • Online ISBN: 978-88-470-1516-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics